<p>Inhibition of the binding of β2GPI-DV by A1 (circles); inhibition of the binding of β2GPI in serum by A1 (triangles).</p
<p><b>(A)</b> AB0041, AB0046, and GS-5745 demonstrate noncompetitive inhibition of MMP9: Antibody-me...
<p>A: Inhibition of serum IgA reactivity to glycoprotein 2 (GP2). A serum with high anti-GP2 IgA lev...
<p>(<b>A</b>) Antibody binding curves against plate-immobilized PFs for SEC-isolated IVIg monomers (...
<p>A) The binding of β2GPI-DV to cardiolipin in the absence (triangles) and in the presence (circles...
<p>Inhibition curves measured for the dimeric inhibitor A1-A1 (circles) and monomeric inhibitor A1 (...
<p>A) The binding of β2GPI in serum to cardiolipin-coated surface in the absence (triangles) and in ...
<p>The purified β2GPI bound to cardiolipin in the absence of anti-β2GPI antibody with increasing amo...
β2GPI is a major antigen for autoantibodies associated with antiphospholipid syndrome (APS), an auto...
β2GPI is a major antigen for autoantibodies associated with antiphospholipid syndrome (APS), an auto...
<p>A) Addition of 600μg GPGRAPI peptide (p<0,01), but not a control peptide significantly decreases ...
<p>(A) RII binds to GpA (lane 1), but not to neuraminidase treated GpA (GpA-NA – lane 2). Addition o...
Monocyte binding has previously been assigned to the Cγ3 domain of human immunoglobulin G (IgG) larg...
<p>Binding of 1 nM [<sup>3</sup>H]NMS to membranes from CHO cells expressing M<sub>2</sub> receptors...
<p>(A) Time-course of normalized molecular concentration of mGFP-GPI in response to the addition of ...
Most antibodies to factor VIII have recently been shown to react with discrete regions of the factor...
<p><b>(A)</b> AB0041, AB0046, and GS-5745 demonstrate noncompetitive inhibition of MMP9: Antibody-me...
<p>A: Inhibition of serum IgA reactivity to glycoprotein 2 (GP2). A serum with high anti-GP2 IgA lev...
<p>(<b>A</b>) Antibody binding curves against plate-immobilized PFs for SEC-isolated IVIg monomers (...
<p>A) The binding of β2GPI-DV to cardiolipin in the absence (triangles) and in the presence (circles...
<p>Inhibition curves measured for the dimeric inhibitor A1-A1 (circles) and monomeric inhibitor A1 (...
<p>A) The binding of β2GPI in serum to cardiolipin-coated surface in the absence (triangles) and in ...
<p>The purified β2GPI bound to cardiolipin in the absence of anti-β2GPI antibody with increasing amo...
β2GPI is a major antigen for autoantibodies associated with antiphospholipid syndrome (APS), an auto...
β2GPI is a major antigen for autoantibodies associated with antiphospholipid syndrome (APS), an auto...
<p>A) Addition of 600μg GPGRAPI peptide (p<0,01), but not a control peptide significantly decreases ...
<p>(A) RII binds to GpA (lane 1), but not to neuraminidase treated GpA (GpA-NA – lane 2). Addition o...
Monocyte binding has previously been assigned to the Cγ3 domain of human immunoglobulin G (IgG) larg...
<p>Binding of 1 nM [<sup>3</sup>H]NMS to membranes from CHO cells expressing M<sub>2</sub> receptors...
<p>(A) Time-course of normalized molecular concentration of mGFP-GPI in response to the addition of ...
Most antibodies to factor VIII have recently been shown to react with discrete regions of the factor...
<p><b>(A)</b> AB0041, AB0046, and GS-5745 demonstrate noncompetitive inhibition of MMP9: Antibody-me...
<p>A: Inhibition of serum IgA reactivity to glycoprotein 2 (GP2). A serum with high anti-GP2 IgA lev...
<p>(<b>A</b>) Antibody binding curves against plate-immobilized PFs for SEC-isolated IVIg monomers (...
DOI
Add to ORKG